美團點評(3690.HK)站上160港元關口再創歷史新高 市值逼近萬億大關
格隆匯6月3日丨入選了格隆匯2020年“下注中國十大核心資產”名單的美團點評(3690.HK)近期不斷刷新高,今日漲幅繼續,盤中最高漲超9%首度站上160港元關口,再創歷史新高,市值突破9300億港元,逼近萬億港元大關,且超過中國石油,位居港股市場第十位,在互聯網行業中僅次於阿里巴巴和騰訊。美團點評自3月19日由70.1港元反彈至今日最高價160.7港元,不到3個月內最大漲幅達129%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.